| The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection S Singh, P Uppuluri, Z Mamouei, A Alqarihi, H Elhassan, S French, ... PLoS pathogens 15 (8), e1007460, 2019 | 106 | 2019 |
| GRP78 and integrins play different roles in host cell invasion during mucormycosis A Alqarihi, T Gebremariam, Y Gu, M Swidergall, S Alkhazraji, ... MBio 11 (3), 10.1128/mbio. 01087-20, 2020 | 77* | 2020 |
| Fosmanogepix (APX001) is effective in the treatment of immunocompromised mice infected with invasive pulmonary scedosporiosis or disseminated fusariosis S Alkhazraji, T Gebremariam, A Alqarihi, Y Gu, Z Mamouei, S Singh, ... Antimicrobial agents and chemotherapy 64 (3), 10.1128/aac. 01735-19, 2020 | 69 | 2020 |
| Fosmanogepix (APX001) is effective in the treatment of pulmonary murine mucormycosis due to Rhizopus arrhizus T Gebremariam, S Alkhazraji, A Alqarihi, NP Wiederhold, KJ Shaw, ... Antimicrobial agents and chemotherapy 64 (6), 10.1128/aac. 00178-20, 2020 | 60 | 2020 |
| Mucoricin is a ricin-like toxin that is critical for the pathogenesis of mucormycosis SSM Soliman, C Baldin, Y Gu, S Singh, T Gebremariam, M Swidergall, ... Nature microbiology 6 (3), 313-326, 2021 | 58 | 2021 |
| Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis T Gebremariam, NP Wiederhold, A Alqarihi, P Uppuluri, N Azie, ... Journal of Antimicrobial Chemotherapy, dkw433, 2016 | 49 | 2016 |
| Inhibition of EGFR signaling protects from mucormycosis TN Watkins, T Gebremariam, M Swidergall, AC Shetty, KT Graf, A Alqarihi, ... MBio 9 (4), 10.1128/mbio. 01384-18, 2018 | 48 | 2018 |
| The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection P Uppuluri, L Lin, A Alqarihi, G Luo, EG Youssef, S Alkhazraji, NY Yount, ... PLoS pathogens 14 (5), e1007056, 2018 | 43 | 2018 |
| APX001 is effective in the treatment of murine invasive pulmonary aspergillosis T Gebremariam, S Alkhazraji, A Alqarihi, HH Jeon, Y Gu, M Kapoor, ... Antimicrobial agents and chemotherapy 63 (2), 10.1128/aac. 01713-18, 2019 | 42 | 2019 |
| Alexidine dihydrochloride has broad-spectrum activities against diverse fungal pathogens Z Mamouei, A Alqarihi, S Singh, S Xu, MK Mansour, AS Ibrahim, ... Msphere 3 (5), 10.1128/msphere. 00539-18, 2018 | 41 | 2018 |
| Metabolic Profiling of Candida auris, a Newly-Emerging Multi-Drug Resistant Candida Species, by GC-MS MH Semreen, SSM Soliman, BQ Saeed, A Alqarihi, P Uppuluri, ... Molecules 24 (3), 399, 2019 | 37 | 2019 |
| Human anti-Als3p antibodies are surrogate markers of NDV-3A vaccine efficacy against recurrent vulvovaginal candidiasis P Uppuluri, S Singh, A Alqarihi, CS Schmidt, JP Hennessey Jr, ... Frontiers in Immunology 9, 1349, 2018 | 34 | 2018 |
| NDV-3A vaccination prevents C. albicans colonization of jugular vein catheters in mice A Alqarihi, S Singh, JE Edwards Jr, AS Ibrahim, P Uppuluri Scientific reports 9 (1), 6194, 2019 | 29 | 2019 |
| APX001A Protects Immunosuppressed Mice from Rhizopus delemar Infection T Gebremariam, S Alkhazraji, A Alqarihi, NP Wiederhold, KJ Shaw, ... Open Forum Infectious Diseases 4 (suppl_1), S475-S475, 2017 | 13 | 2017 |
| Galactomannan is a biomarker of fosmanogepix (APX001) efficacy in treating experimental invasive pulmonary aspergillosis T Gebremariam, S Alkhazraji, Y Gu, S Singh, A Alqarihi, KJ Shaw, ... Antimicrobial agents and chemotherapy 64 (1), 10.1128/aac. 01966-19, 2019 | 12 | 2019 |
| Mucormycosis in 2023: An update on pathogenesis and management A Alqarihi, DP Kontoyiannis, AS Ibrahim Frontiers in Cellular and Infection Microbiology 13, 2023 | 10 | 2023 |
| Evaluation of sex differences in murine diabetic ketoacidosis and neutropenic models of invasive mucormycosis T Gebremariam, S Alkhazraji, A Alqarihi, NP Wiederhold, LK Najvar, ... Journal of Fungi 7 (4), 313, 2021 | 9* | 2021 |
| An evolutionarily diverged mitochondrial protein controls biofilm growth and virulence in Candida albicans Z Mamouei, S Singh, B Lemire, Y Gu, A Alqarihi, S Nabeela, D Li, ... PLoS biology 19 (3), e3000957, 2021 | 9 | 2021 |
| Inhibition of EGFR signaling protects from mucormycosis. mBio 9: e01384-18 TN Watkins, T Gebremariam, M Swidergall, AC Shetty, KT Graf, A Alqarihi, ... | 8 | 2018 |
| Alexidine dihydrochloride has broad-spectrum activities against diverse fungal pathogens. mSphere 3: e00539-18 Z Mamouei, A Alqarihi, S Singh, S Xu, MK Mansour, AS Ibrahim, ... | 7 | 2018 |
Ashraf IbrahimDavid Geffen School of Medicine at UCLA; The Lundquist Institute at Harbor-UCLA Medical CenterVerified email at lundquist.org
